Terumo Corp. (OTCMKTS:TRUMY) Sees Large Growth in Short Interest

Terumo Corp. (OTCMKTS:TRUMY) was the target of a significant growth in short interest in May. As of May 29th, there was short interest totaling 147,141 shares, a growth of 946.0% from the May 14th total of 14,067 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 332,773 shares, the days-to-cover ratio is currently 0.4 days.

Terumo Trading Down 1.9%

Shares of TRUMY stock opened at $14.18 on Wednesday. The stock’s fifty day moving average is $13.63 and its two-hundred day moving average is $13.82. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.89 and a current ratio of 1.51. The firm has a market capitalization of $20.92 billion, a P/E ratio of 23.25 and a beta of 0.67. Terumo has a fifty-two week low of $12.08 and a fifty-two week high of $19.60.

Terumo (OTCMKTS:TRUMY) last issued its earnings results on Friday, May 15th. The company reported $0.11 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.11. Terumo had a return on equity of 9.35% and a net margin of 12.09%.The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.84 billion. Research analysts expect that Terumo will post 0.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently issued reports on TRUMY. Nomura upgraded shares of Terumo to a “hold” rating in a report on Tuesday, February 24th. Zacks Research upgraded Terumo to a “hold” rating in a research report on Thursday, April 9th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Terumo currently has an average rating of “Hold”.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.